Transgender Post-reassignment Urogynecologic Measures and Perceptions

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 27, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Gender Identity Disorder of AdultVoiding DisordersSexual Dysfunction
Interventions
OTHER

Focus group interviews

Focus group participants will be asked about their postoperative urogynecologic experience. Confidentiality will be enforced and participants will be made aware that they may opt out of answering any questions.

DIAGNOSTIC_TEST

Questionnaire packet

Participants will be asked to complete a questionnaire packet comprised of three previously validated questionnaires and one newly created focused questionnaire. They will be asked to complete the new questionnaire again 2 weeks later. We estimate about 10 minutes will be required to complete the packet.

Trial Locations (1)

10065

RECRUITING

Weill Cornell Medicine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

Boston Medical Center

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT03293771 - Transgender Post-reassignment Urogynecologic Measures and Perceptions | Biotech Hunter | Biotech Hunter